NRC Health Accounts Receivable, Allowance for Credit Loss
NRC Health (NRC) had Accounts Receivable, Allowance for Credit Loss of $80.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-03-05
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $80.00K.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss $50.00K.
- 2025-06-30: Accounts Receivable, Allowance for Credit Loss $40.00K.
- 2025-03-31: Accounts Receivable, Allowance for Credit Loss $40.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2025-12-31 | $80.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $50.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $40.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $40.00K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $40.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $45.00K 10-Q · filed 2025-11-07 |
| 2024-06-30 | $50.00K 10-Q · filed 2025-08-08 |
| 2024-03-31 | $75.00K 10-Q · filed 2025-05-09 |
| 2023-12-31 | $75.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $85.00K 10-Q · filed 2024-11-08 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-08 |
| 2023-03-31 | $65.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $65.00K 10-K · filed 2026-03-05 |
| 2022-09-30 | $65.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $65.00K 10-Q · filed 2023-08-04 |
| 2022-03-31 | $69.00K 10-Q · filed 2023-05-05 |
| 2021-12-31 | $94.00K 10-K · filed 2025-03-17 |
| 2021-09-30 | $94.00K 10-Q · filed 2022-11-04 |
| 2021-06-30 | $107.00K 10-Q · filed 2022-08-05 |
| 2021-03-31 | $119.00K 10-Q · filed 2022-05-06 |
| 2020-12-31 | $120.00K 10-K · filed 2024-02-27 |
| 2020-09-30 | $126.00K 10-Q · filed 2021-11-05 |
| 2020-06-30 | $143.00K 10-Q · filed 2021-08-06 |
| 2020-03-31 | $143.00K 10-Q · filed 2021-05-07 |
| 2019-12-31 | $144.00K 10-K · filed 2023-03-03 |
| 2019-09-30 | $138.00K 10-Q · filed 2020-11-06 |
| 2019-06-30 | $124.00K 10-Q · filed 2020-08-07 |
| 2019-03-31 | $138.00K 10-Q · filed 2020-05-08 |
| 2018-12-31 | $175.00K 10-K · filed 2022-03-04 |
| 2017-12-31 | $200.00K 10-K · filed 2021-03-05 |
| 2016-12-31 | $169.00K 10-K · filed 2020-03-06 |
| 2015-12-31 | $173.00K 10-K · filed 2019-03-08 |
| 2014-12-31 | $206.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |